Tauns Laboratories Updates Mid-Term Business Plan After Correction

TOKYO, Jul 24 (Pulse News Wire) – Tauns Laboratories,inc. (197A.T) corrected a portion of its previously disclosed mid-term business plan update on July 15, 2026.

The correction pertains to the presentation method of certain figures in the document, which had inconsistently used rounding methods. Specifically, the company unified the notation from mixed rounding and truncation to consistent truncation. The revised figures show the forecasted operating profit for the fiscal year ending June 2026 changing from ¥4.400 billion (truncated) to ¥4.300 billion (truncated).

However, the overall outlook for the fiscal year and the mid-term business plan remain unchanged. For detailed corrections, refer to the attached document. The updated operating profit forecast remains based on the revision announced on March 30, 2026, which set the figure at ¥4.368 billion.

The correction does not alter the company's projected performance or strategic plans.